These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2012-003561-17 A Phase 2 open-label, dose-escalation study to evaluate the safety, pharmacokinetics, immunogenicity and pharmacodynamics/efficacy of EDI200, an EDA-A1 replacement protein, administered to male infant... 2016-03-17 due-trials
Listed as ongoing, but also has a completion date 2013-004565-14 Extension Study of XLHED-Affected Male Subjects treated with EDI200 in Protocol ECP-002 2016-10-07 bad-data